Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued payments due to AstraZeneca	$ 3,680	$ 3,385
Accrued gross to net revenue liabilities	3,258	1,991
Accrued contract manufacturing expenses	1,946	1,657
Accrued sales and marketing expenses	3,223	587
Accrued professional and consulting services	486	808
Derivative liability for exit fees	675	1,656
Accrued clinical expenses	377	223
Accrued non-clinical research and development expenses	30	1,188
Other	1,366	885
Total accrued expenses and other current liabilities	$ 15,041	$ 12,380